Dosing of Remifentanil to Prevent Movement During Craniotomy in the Absence of Neuromuscular Blockade
Authors:
- Marco A. MaurtuaMMMarco A. Maurtua
- Anupa DeogaonkarADAnupa Deogaonkar
- Mohamed H. BakriMBMohamed H. Bakri
- Edward MaschaEMEdward Mascha
- Jie NaJNJie Na
- Joseph FossJFJoseph Foss
- Daniel I. SesslerDSDaniel I. Sessler
- Michelle LottoMLMichelle Lotto
- Zeyd EbrahimZEZeyd Ebrahim
- Armin SchubertASArmin Schubert
- 1 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 20 (4) , 221-225
Abstract
In neuroanesthesia practice, muscle relaxants may at times need to be avoided to facilitate intraoperative motor pathway monitoring. Our study's objective was to determine the optimal dose of remifentanil required to prevent movement after neurosurgical stimulation. After Institutional Review Board approval and written informed consent, 132 patients undergoing elective craniotomy randomly received one of 12 remifentanil dose regimens (0.10 to 0.21 microg/kg/min). Remifentanil was started before induction with propofol and succinylcholine. Anesthesia was maintained with isoflurane (0.6% end-tidal) in air/oxygen. During the study, movement was assessed on predetermined criteria by the anesthesiology, nursing, and neurosurgical teams. Heart rate and blood pressure were recorded every 5 minutes. We assessed the relationship between movement, hypotension, bradycardia, and dose using probit analysis and logistic regression. Sixty-five percent of the patients moved in response to surgical stimuli [95% confidence interval (CI): 49%-79%] at a remifentanil infusion rate of 0.10 microg/kg/min, and movement decreased to 21% (95% CI: 11-35) at 0.21 microg/kg/min. The probability of movement was 50% at an infusion rate (95% CI) of 0.13 (0.10 to 0.15) microg/kg/min remifentanil and decreased to 25% at an infusion rate of 0.19 (0.17 to 0.29) microg/kg/min. The probability of hypotension and bradycardia was 50% at 0.13 (0.10 to 0.15) microg/kg/min and 0.17 (0.15 to 0.21) microg/kg/min, respectively. Higher doses of remifentanil lessen the risk of movement in the absence of muscle relaxants with surgical stimulation for elective craniotomy. Hypotension and bradycardia were common at higher doses. Even at the maximum dose (0.21 mcg/kg/min) there was a 20% chance of movement. Adjunctive therapy is needed to ablate movement reliably, and to counteract the hypotensive effect of remifentanil. These findings may be helpful for clinicians administering remifentanil and isoflurane during procedures, where muscle relaxants may not be desirable.Keywords
This publication has 8 references indexed in Scilit:
- A comparison of intubating conditions in children following induction of anaesthesia with propofol and suxamethonium or propofol and remifentanilAnaesthesia, 2006
- A Comparison of Effects of Alfentanil, Fentanyl, and Remifentanil on Hemodynamic and Respiratory Parameters During Stereotactic Brain BiopsyJournal of Neurosurgical Anesthesiology, 2006
- Remifentanil‐sevoflurane anaesthesia for laparoscopic cholecystectomy: comparison of three dose regimensAnaesthesia, 2002
- Effects of perfusion pressure on tissue perfusion in septic shockCritical Care Medicine, 2000
- Awareness during AnesthesiaAnesthesiology, 2000
- Reduction of Isoflurane Minimal Alveolar Concentration by RemifentanilAnesthesiology, 1996
- Determination and Applications of MACAnesthesiology, 1980
- CHANGING CONCEPTS CONCERNING DEPTH OF ANESTHESIAEAnesthesiology, 1957